Affiliations 

  • 1 a Immunology Research Center , Tabriz University of Medical Sciences , Tabriz , Iran
  • 2 c Nutrition Research Center, Tabriz University of Medical Sciences , Tabriz , Iran
  • 3 b Department of Human Anatomy, Faculty of Medicine and Health Sciences, UPM , Selangor , Malaysia
Artif Cells Nanomed Biotechnol, 2018 Dec;46(8):1792-1798.
PMID: 29113504 DOI: 10.1080/21691401.2017.1392969

Abstract

Acute myeloid leukaemia (AML) is a genetically heterogeneous, severe and rapidly progressing disease triggered by blocking granulocyte or monocyte differentiation and maturation. Overexpression of myeloid cell leukaemia-1 (Mcl-1) and Survivin is associated with drug resistance, tumour progression and inhibition of apoptotic mechanisms in leukaemia and several cancers. In the present study, we examined the combined effect of etoposide and dual siRNA-mediated silencing of Mcl-1 and Survivin on U-937 AML cells. The AML cells were co-transfected with Mcl-1 and Survivin-specific siRNAs and genes silencing were confirmed by quantitative real-time PCR and Western blotting. Subsequently, MTT assay was used for the evaluation of cytotoxic effects by dual siRNA and etoposide on their own and in combination. For the studying of apoptosis, DNA-histone ELISA and annexin-V/FITC assays were performed. Co-transfection of Mcl-1 and Survivin siRNA significantly blocked their expression at the mRNA and protein levels, leading to the induction of apoptosis and strong inhibition of growth (p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications